# SBI US Gateway Fund

> SBI US Gateway Fund is a VC fund in Seattle backing Comics, Biopharma and Publishing. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seattle, United States
- Total investments: 6
- Last investment: Mar 2026
- Lead investor: 17%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/sbi-us-gateway-fund

SBI US Gateway Fund is a VC fund in Seattle focused on Comics and Biopharma. SBI US Gateway is a venture fund. It is a joint fund by SBI Holdings, Inc. and Shin Nippon Biomedical Laboratories in partnership with Plug and Play.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Comics | 1 | 17% |
| Biopharma | 1 | 17% |
| Publishing | 1 | 17% |
| Health Care | 1 | 17% |
| Life Science | 1 | 17% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Pre-Seed | 2 | 33% |
| Series A | 2 | 33% |
| Seed | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| GlobalComix | GlobalComix is a free digital reading and distribution platform that helps creators and publishers share and sell their comics. GlobalComix helps readers understand the value of artistic labor and help creators earn cash in more consistent and flexible ways. Most importantly, GlobalComix promotes cross-cultural exchange and help comics fans andmakers connect with each other in deeper, more insightful ways. | $13M | Venture - Series Unknown | Mar 18, 2026 |  |
| Avisi Technologies | Avisi Technologies develops ophthalmic medical devices using nanotechnology to address vision loss associated with glaucoma and related eye conditions. The company designs implantable solutions such as VisiPlate, an aqueous shunt that regulates intraocular fluid through microchannel structures to help manage eye pressure. Its work combinesmaterials science and ophthalmology to create minimally invasive devices intended for long-term function within the eye. | $10.8M | Series A | Feb 25, 2026 |  |
| Sift Biosciences | Sift Biosciences is a biotechnology research company that offers cancer therapies. | $3.8M | Pre-Seed | Dec 19, 2025 |  |
| Hearvana | Hearvana is a IT consulting company. | $6M | Pre-Seed | Nov 05, 2025 |  |
| Kite AI | Kite AI is a purpose-built, EVM-compatible L1 designed to power the AI economy. | $18M | Series A | Sep 02, 2025 |  |
| Kite AI | Kite AI is a purpose-built, EVM-compatible L1 designed to power the AI economy. | $15M | Seed | Aug 01, 2023 |  |

6 of 6 investments shown.

## Co-investors
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 3 deals together
- [Hashed](https://shizune.co/investors/profile/hashed-f96b) — VC Fund, 2 deals together
- [LayerZero Labs](https://shizune.co/investors/profile/layerzero-labs) — VC Fund, 2 deals together
- [Plug and Play](https://shizune.co/investors/profile/plug-and-play-ventures) — VC Fund, 2 deals together
- [Point72 Ventures](https://shizune.co/investors/profile/point72-ventures) — VC Fund, 2 deals together
- [Samsung NEXT](https://shizune.co/investors/profile/samsungnext) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund

## FAQ

### What does SBI US Gateway Fund invest in?

SBI US Gateway Fund invests primarily in Comics, Biopharma and Publishing startups, most often at Pre-Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did SBI US Gateway Fund last invest?

The most recent investment recorded for SBI US Gateway Fund closed in Mar 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co